What are you looking for? Write the name, title or any keyword related to what you are looking for and select which content category it belongs to. Search Fulltext search Activities Professionals Research groups News - Any - News Identified the genes responsible of the incomes for intensive care patients with A flu A research team from Vall d'Hebron Research Institute (VHIR) have studied the immunological answer in the patients who required income to Intensive Cares for severe pneumonia during the acute phase of the A flu. The conclusions of the study indicate that, in those most severe cases, the failure of t News Catalonian Health Minister opens Collserola Building, VHIR's new facilities Catalonian Health Minister, Marina Geli, opened on Wednesday 22 September the new facilities of Vall d'Hebron Research Institute (VHIR), Building Collserola. Building Collserola, made with the support of P.O. FEDER2007-2013, will host nearly 200 scientists in its 2500 m2, and complements the Medit News Stopping antiplatelet therapy after a drug active stent placement increases high risk of thrombosis Researchers from Vall d'Hebron Research Institute (VHIR) lead a study showing epidemiological data on the causes and consequences of noncompliance with antiplatelet therapy with platelet after placement of a drug-eluting stent or drug active stent. Due to the severity of the effects of stopping t News Alicia Koplowitz Foundation provides significant funds to a project coordinated by Dr. Comabella A project coordinated by Dr. Manuel Comabella, member of the Neuroimmunologia Group at Vall d'Hebron Research Institute (VHIR), in which also participates Rana Moubarak, a member of Cell Signaling and apoptosis research group, has received a substantial fund from the Alicia Koplowitz Foundation. T News Discovered new markers of risk and response to treatment in ictus The Neurvascular Laboratory of Vall d'Hebron Research Institute (VHIR) found some genetic variants that, on the one hand, represent an indicator of response to treatment in ictus as a marker and, secondly, is associated with increased risk for this disease. These results are the fruit of a long his News The scientific perspective on intersexuality Dr. Laura Audi, member of the Endicronology Paediatric Unit at Vall d'Hebron Research Institute (VHIR) gives her views on intersexuality. Years ago, it was assigned one sex to the baby that eventually, could be wrong. Now, thanks to advances in genetic, morphological and hormonal studies, is possib News A study explores the relationship between personality patterns and the different subtypes of ADHD Researchers from Vall d'Hebron Research Institute (VHIR) have established clear relationships between different personality patterns of patients with Attention Deficit Disorder and Hyperactivity Disorder (ADHD) and disorder subtypes that these patients suffer. The results of this study, published News New expectations for the treatment of metabolic diseases Researchers from Vall d'Hebron Research Institute (VHIR) lead an unprecedented study that shows that it is possible to modify the composition of the intestinal flora transplanting it, and that generated changes remain, beyond expectations, up to three months after transplantation. The ability to v News VHIR stands out in an h index ranking Researchers of Vall Hebron Institute de Recerca (VHIR) occupy a prominent position in a ranking that publishes a list of the best Spanish researchers according the h index. It consists on a method that evaluates the impact of scientific research in different areas of knowledge. According to the stud News End of Pandemic Influenza A: Reviews of Dr. Rello As coordinator of the European Registry of severe cases of A influenza, Dr. Rello, Head of Research Group on sepsis and severe respiratory infection of VHIR, summarizes the management of the first pandemic of the XXI century in the tv show 'Els Matins', of TV3. News Dr. Montalban opinion about Salvitex on the market Chief of Clinical Neuroimmunology at Vall d'Hebron Research Institute (VHIR), Dr. Xavier Montalban, talks about the green light from the health authorities to market Sativex in Spain, a drug derived from cannabis for the treatment of spasticity in multiple sclerosis patients. News Described for the first time a key protein in cell mitosis A study led by Dr. Rosanna Paciucci, member of the Biomedical Research and traslational Oncology Unit at VHIR, and published in the Journal of Biological Chemistry, describes for the first time how key is Flotilina 1 for the correct separation of chromosomes during cell mitosis. This protein, presen News Trobada entre els investigadors del Vall d'Hebron i els IDIAP Jordi Gol El passat 16 d'abril va tenir lloc la trobada entre investigadors de l'Hospital Vall d'Hebron i investigadors de l'atenció primària de salut de Catalunya, dins del marc de les VII Jornades d'Excel·lència en la Recerca d'Atenció Primària organitzades per l'Institut d'Investigació en Atenció Primària News Els fàrmacs orals aterren en el tractament de l'esclerosi múltiple Tres estudis clínics en fase III amb una àmplia mostra de pacients (cadascun inclou més de mil) han demostrat la clara eficàcia de dues molècules orals, fingolimod i cladribina, davant placebo en el tractament de l'esclerosi múltiple. En el cas de fingolimod, un dels assaigs també indica que és supe News ICS Research institutes sign an agreement with B.Braun to develope a program to investigate surgical technology Three research institutes assigned to Institut català de la salut (ICS),-Germans Trias i Pujol, Vall d’ Hebron and Bellvitge hospitals- have subscribed a research and innovation program with B.Braun Group to help investigation about surgical technology improvement. Each Institut will have a mana News Vall d' Hebron presents research activities and bets for innovation and fundraising Vall d'Hebron Research Institute presented the report of research activities 2009/10 at the conference’s room at 10th floor in the Hospital General area. The first speaker who initiated the act was the manager of the hospital, Dr. Jose Luis de Sancho. He made a positive evaluation of the work done t News Awarded a segmentary and local child glomeruloesclerosis study Catalan nephrology society (Societat catalana de nefrologia) has recently granted with best clinic work to a segmentary adn local child glomeruloesclerosis study from Vall d'Hebron Research Institute (VHIR) investigators and paediatric nephrology service from the same hospital. The study includes ne News VHIR overcomes 70 patents Diario Medico' points out in a recent article that Vall d'Hebron Research Institute (VHIR) overcomes 70 patents. It is one of the most important items in an article where last VHIR innovations are revised and where Dr. Joan X. Comella, its director, explains the state of several projects. The articl News Dr. Alijotas gives some clues about implants In a wide interview with Group Vocento 'XL Semanal', Dr Alijoats, responsible of the aging unite at Vall d'Hebron Research Institute, explains his experience with implants. News VHIR coordinates a new European Project that studies repetitive spontaneous abortions Vall d’ Hebron Research Institute (VHIR) coordinates an European register that includes information about antiphospholipid sindrome (APS) associated with bad pregnancy precedents. (spontaneous abortions, fetus deaths, complications during pregnancy…) Pagination First page « Previous page ‹ … Page 165 Page 166 Current page 167 Page 168 Page 169 … Next page › Last page »
